Evoke Pharma Inc (EVOK)

5.09 -0.40 (-7.29%) USD  |  NASDAQ  |  Dec 20, 16:00
5.02 -0.07 (-1.38%) After-Hours: 20:00
More

Evoke Pharma Max Drawdown (5Y): 99.53% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for EVOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Eli Lilly and Co 24.12%
MEI Pharma Inc 96.19%
Revance Therapeutics Inc 93.78%
NovaBay Pharmaceuticals Inc 99.98%
Palatin Technologies Inc 97.38%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -59.53
Beta (5Y) 0.1617
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 94.60%
Historical Sharpe Ratio (5Y) -0.6065
Historical Sortino (5Y) -1.349
Monthly Value at Risk (VaR) 5% (5Y Lookback) 37.84%